Bicara Therapeutics Adds Jeremy Bender and Christy Oliger to Board as Commercialization Nears

Bicara Therapeutics (Nasdaq: BCAX) has appointed biotechnology executives Jeremy Bender and Christy Oliger to its Board of Directors, strengthening its... Read More

The post Bicara Therapeutics Adds Jeremy Bender and Christy Oliger to Board as Commercialization Nears appeared first on citybiz.